Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
KEYT 3 Santa Barbara· 5 days agoUS challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 5 days agoThe letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and...
10 of the Best Fund Managers Focused on Large-Cap Stocks
Morningstar· 4 days agoIn an effort to find new stock picks for investors to research further, we often turn to the portfolio holdings of top concentrated fund managers. By our definition, the best fund managers running ...
US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
Pittsburgh Tribune-Review· 5 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KSAN - KLST San Angelo· 5 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
FTC challenges ‘bogus’ patents on Ozempic, other drugs that ‘block competition’
Market Watch· 5 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KTLA-TV Los Angeles· 5 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Houston Chronicle· 5 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 5 days agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Antonio Express-News· 5 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...